Questions & Answers

The Veltmeyer Protocol involves utilization of various interventions before injection of stem cells such that the disease-induced elements which make the body hostile to stem cells are minimized. 

According to the Veltmeyer Protocol, blood levels of these toxic agents associated with reduction of stem cell viability and activity are measured before stem cell therapy.  Patients are placed on disease and patient specific interventions.  Only when the patient’s body is ready to receive the stem cells — because it has been properly detoxified — are the stem cells administered. 

JadiCell is an investigational umbilical cord stem cell therapy which is currently under Phase III clinical development by the FDA.

JadiCells are mesenchymal stem cells (MSCs), a type of adult stem cell in several tissues throughout the body. MSCs can self-renew and give rise to many different cell types in the body. They have garnered substantial attention for their anti-inflammatory, neuro-protective, and regenerative abilities.

JadiCells, which are derived from the lining of the umbilical cord, might be superior to other stem cells at producing certain therapeutic factors and can be stimulated in different ways to further boost their regenerative capacity.

Preclinical studies showed JadiCells outperformed stem cells from other sources — including those derived from bone marrow or adipose (fatty) tissue — in their ability to reduce lung injury in a mouse model of emphysema, a severe form of COPD. Data also showed that JadiCells may lower some pro-inflammatory protein levels, while increasing those of anti-inflammatory markers.

Additionally, we have seen great success with JadiCells in the treatment of ALS, autism, epilepsy and seizures, Post Traumatic Stress Disease and chronic traumatic encephalopathy.

California Advanced Biologics is a regenerative medicine company that is legally capable of offering stem cells under the Right to Try Law. CAB treats patients suffering from chronic degenerative conditions for which limited or no medical treatments currently exist. VI is the preferred choice due to its unique utilization of a specific protocol that detoxifies and prepares the body to receive and benefit from the stem cell infusions. CAB has exclusive access to JadiCells which are an exceptionally potent type of Adult Stem Cells. Studies have demonstrated that JadiCells are therapeutically superior to any other form of stem cells available today. Data shows that JadiCells have been successful in the treatment of ALS, autism, epilepsy, and seizures. Additionally, 62 randomized clinical trials of 3546 patients have shown no adverse events associated with stem cell therapy.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.